Abstract: A charge eliminating apparatus configured to remove charges from a sheet on which an image is formed by a printing apparatus, includes a charge eliminating roller pair including a first charge eliminating roller and a second charge eliminating roller configured to form a nip portion together with the first charge eliminating roller, the charge eliminating roller pair being configured to remove the charges from the sheet in a state of contacting the sheet at the nip portion, a first setting unit configured to set a value of a voltage applied to the charge eliminating roller pair, and a second setting unit configured to set whether to apply the voltage to the charge eliminating roller pair, wherein the second setting unit is configured to set whether to apply the voltage to the charge eliminating roller pair without changing the value of the voltage set by the first setting unit.

Abstract: A charge eliminating apparatus configured to remove charges from a sheet on which an image is formed by a printing apparatus, includes a charge eliminating roller pair including a first charge eliminating roller and a second charge eliminating roller configured to form a nip portion together with the first charge eliminating roller, the charge eliminating roller pair being configured to remove the charges from the sheet in a state of contacting the sheet at the nip portion, a first setting unit configured to set a value of a voltage applied to the charge eliminating roller pair, and a second setting unit configured to set whether to apply the voltage to the charge eliminating roller pair, wherein the second setting unit is configured to set whether to apply the voltage to the charge eliminating roller pair without changing the value of the voltage set by the first setting unit.

Abstract: Provided is an anti-inflammatory composition which has a high efficacy, causes no concern about side effects, is easy to ingest, and can also be administered for a long period of time because of its low cost and high safety. The present invention relates to a peptide comprising an amino acid sequence represented by pyroGlu-(X)n-A or a salt thereof, wherein X is independently Gln, Asn, or Pro; A represents Gln, Asn, Leu, Ile, Met, Val, or Phe; and n represents an integer of 0 to 2, and an anti-inflammatory composition comprising the same.

Abstract: This invention provides a composition having preventive and/or therapeutic effects on liver disease, which is highly effective, free of side effects, easily ingestible, and capable of long-term ingestion from the viewpoint of a cost and safety. This invention relates to a peptide having the amino acid sequence represented by the following formula: pyroGlu-(X)n-A, wherein X is the same or different and represents Gln or Asn; A represents Gln, Asn, Leu, Ile, or Val; and n is an integer from 0 to 2 or a salt thereof.

Abstract: Fluorescent 1-peptidylaminoalkanephosphonate derivatives, and their use in detecting and studying the distribution of serine proteases in cells and biological systems.